Literature DB >> 21474251

Chronic fatigue syndrome--a neuroimmunological model.

S V Arnett1, L M Alleva, R Korossy-Horwood, I A Clark.   

Abstract

The aetiological and pathophysiological basis of chronic fatigue syndrome (CFS) remains a controversial field of inquiry in the research community. While CFS and similar disease conditions such as fibromyalgia (FM) and post-infectious encephalopathy have been the focus of intense scrutiny for the past 20 years, results of research were often contradictory and a cohesive pathological model has remained elusive. However, recent developments in understanding the unique immunophysiology of the brain may provide important clues for the development of a truly comprehensive explanation of the pathology of CFS. We argue that CFS pathogenesis lies in the influence of peripheral inflammatory events on the brain and the unique immunophysiology of the central nervous system. There is also evidence that CFS patients have a relative immunodeficiency that predisposes to poor early control of infection that leads to chronic inflammatory responses to infectious insults. The neurological and endocrine changes have been described in CFS patients support the view that CFS has an inflammatory pathogenesis when considered as a whole. An inflammatory model of disease also provides an explanation for the marked female sex bias associated with CFS. This review therefore posits the hypothesis that CFS as a disease of long-term inflammatory processes of the brain. We will also provide an investigative framework that could be used to justify the use of anti-TNF biological agents as a reliable and effective treatment approach to CFS, a syndrome that to date remains frustratingly difficult for both patients and health care professionals to manage.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21474251     DOI: 10.1016/j.mehy.2011.03.030

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  12 in total

1.  Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines.

Authors:  Melissa N Garcia; Anne M Hause; Christopher M Walker; Jordan S Orange; Rodrigo Hasbun; Kristy O Murray
Journal:  Viral Immunol       Date:  2014-07-25       Impact factor: 2.257

2.  [Etiopathogenetic aspects of somatoform disorders].

Authors:  M Noll-Hussong; H Gündel
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

Review 3.  Neuroinflammation disorders exacerbated by environmental stressors.

Authors:  James P O'Callaghan; Diane B Miller
Journal:  Metabolism       Date:  2019-11       Impact factor: 8.694

Review 4.  Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.

Authors:  Timothy L Wong; Danielle J Weitzer
Journal:  Medicina (Kaunas)       Date:  2021-04-26       Impact factor: 2.430

5.  Hemodialysis fatigue: just "simple" fatigue or a syndrome on its own right?

Authors:  Giorgos K Sakkas; Christina Karatzaferi
Journal:  Front Physiol       Date:  2012-07-31       Impact factor: 4.566

6.  Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Authors:  Ekua W Brenu; Mieke L van Driel; Don R Staines; Kevin J Ashton; Sandra B Ramos; James Keane; Nancy G Klimas; Sonya M Marshall-Gradisnik
Journal:  J Transl Med       Date:  2011-05-28       Impact factor: 5.531

Review 7.  Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder.

Authors:  Masaaki Tanaka; Seiki Tajima; Kei Mizuno; Akira Ishii; Yukuo Konishi; Teruhisa Miike; Yasuyoshi Watanabe
Journal:  J Physiol Sci       Date:  2015-09-29       Impact factor: 2.781

Review 8.  Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Authors:  Leonard A Jason; Marcie L Zinn; Mark A Zinn
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 9.  The clinical value of cytokines in chronic fatigue syndrome.

Authors:  Tiansong Yang; Yan Yang; Delong Wang; Chaoran Li; Yuanyuan Qu; Jing Guo; Tianyu Shi; Wang Bo; Zhongren Sun; Tetsuya Asakawa
Journal:  J Transl Med       Date:  2019-06-28       Impact factor: 5.531

10.  Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Lena Lutz; Johanna Rohrhofer; Sonja Zehetmayer; Michael Stingl; Eva Untersmayr
Journal:  Biomolecules       Date:  2021-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.